Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 11/2018

01-11-2018 | Letter to the Editor

Trends in BMI, Glycaemic Control and Obesity-Associated Comorbidities After Explantation of the Duodenal-Jejunal Bypass Liner (DJBL)

Authors: Radwan Kassir, Jean Gugenheim, Imed Ben Amor, Rani Kassir, Frédérique Sauvat

Published in: Obesity Surgery | Issue 11/2018

Login to get access

Excerpt

Obesity is a major health problem that contributes to increased morbidity and mortality and to a host of disease processes. A growing number of countries adopted policies to prevent obesity from spreading further. Several countries developed multi-stakeholder frameworks, involving business and civil society actors in the development of public health policies. The management and treatment of obesity is complex. A large number of specialists are needed to support health care in obese patients, especially endocrinologists, dieticians, gastroenterologists, surgeons, psychologists and psychiatrists. Gastrointestinal endoscopy is now an investigation of choice for the gastrointestinal tract—mainly oesophagus, stomach and duodenum. …
Literature
1.
2.
Muñoz R, Dominguez A, Muñoz F, et al. Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients. Surg Endosc. 2014 Apr;28(4):1056–62.CrossRefPubMed
3.
Lässle C, Laubner K, Schwacha H, Seufert J, Grueneberger JM, Fischer A, Karcz WK, Hopt UT, Marjanovic G, Kuesters S. Endoscopy. 2014;46 Suppl 1 UCTN:E171-2. Minimally invasive treatment of a duodenal perforation associated with the EndoBarrier duodenal-jejunal bypass linerCrossRefPubMed
4.
Escalona A, Pimentel F, Sharp A, et al. Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner. Ann Surg. 2012 Jun;255(6):1080–5.CrossRefPubMed
Metadata
Title
Trends in BMI, Glycaemic Control and Obesity-Associated Comorbidities After Explantation of the Duodenal-Jejunal Bypass Liner (DJBL)
Authors
Radwan Kassir
Jean Gugenheim
Imed Ben Amor
Rani Kassir
Frédérique Sauvat
Publication date
01-11-2018
Publisher
Springer US
Published in
Obesity Surgery / Issue 11/2018
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-018-3438-y

Other articles of this Issue 11/2018

Obesity Surgery 11/2018 Go to the issue

Original Contributions

Update: 10 Years of Sleeve Gastrectomy—the First 103 Patients

Review Article

More than an Anti-diabetic Bariatric Surgery, Metabolic Surgery Alleviates Systemic and Local Inflammation in Obesity

Brief Communication

Causal Attributions for Obesity Among Patients Seeking Surgical Versus Behavioral/Pharmacological Weight Loss Treatment

Letter to Editor/LED Reply

Reply to Letter to the Editor “Left Gastric Artery Embolization for Weight Loss—a Dead-End Procedure”

Original Contributions

Clinical Characteristics of Roux-en-Y Gastric Bypass Patients with Death from Accidental Overdose or Intentional Self-Harm: a Descriptive Study

Letter to the Editor

Letter to the Editor in Response to “Elipse Balloon: the Pitfalls of Excessive Simplicity” by Angrisani, L., Santonicola, A., Vitiello, A. et al. OBES SURG (2018) 28: 1419